Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Molecular Biology›Mitosis
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Mitosis

Molecular Biology · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 3 min read

A type of cell nucleus division by means of which the two daughter nuclei normally receive identical complements of the number of chromosomes of the somatic cells of the species.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (585 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A type of cell nucleus division by means of which the two daughter nuclei normally receive identical complements of the number of chromosomes of the somatic cells of the species.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Mitoses; M Phase, Mitotic; Mitotic M Phase; Mitotic M Phases; M Phases, Mitotic; Phase, Mitotic M; Phases, Mitotic M.

Where it fits in the MeSH classification

Broader topics
Cell Nucleus Division
Narrower topics
Anaphase; M Phase Cell Cycle Checkpoints; Metaphase; Prometaphase; Prophase; Telophase
See also
Mitogens; Mitotic Index; Maturation-Promoting Factor; Antimitotic Agents

Related concepts

  • Cell Nucleus
  • Chromosomes

Research landscape

PubMed indexes 61,551 records tagged with the MeSH heading “Mitosis” (counts retrieved 2026-10-29). 4,460 of them (7.2%) were published from 2020 onward, and the busiest period so far is through 1999 with 32,755 records.

Reviews account for 5,024 records (8.2%) and meta-analyses for 5. Randomized controlled trials number 52 (0.1%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 32,755 records; 2000-2009: 12,312 records; 2010-2019: 12,024 records; 2020 onward: 4,460 records32,755through 199912,3122000-200912,0242010-20194,4602020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 199932,755
2000-200912,312
2010-201912,024
2020 onward4,460
Share of records by publication typeReviews: 8.2 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.1 percentReviews8.2% (5,024)Meta-analyses0.0% (5)Randomized controlled trials0.1% (52)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 61,551 PubMed records
TypeRecordsShare
Reviews5,0248.2%
Meta-analyses50.0%
Randomized controlled trials520.1%

Method: PubMed query "Mitosis"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in molecular biology

Molecular biology establishes mechanisms through controlled experiments, often in simplified systems such as purified proteins, cultured cells or model organisms. Such work can show what is possible in a defined system, but whether a pathway matters in a whole organism or in human disease needs further evidence. Check the experimental system, whether findings were reproduced by independent groups, and whether the authors tested the mechanism directly or inferred it from correlation.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Rules of engagement for condensins and cohesins guide mitotic chromosome formation
Samejima K, Gibcus JH, Abraham S, Cisneros-Soberanis F, Samejima I, Beckett AJ, et al.
2025Research article
Design not recorded in structured metadata
73cc by
PMID 40208986 · DOI · PMC12118822
Dynamics of microcompartment formation at the mitosis-to-G1 transition
Goel VY, Aboreden NG, Jusuf JM, Zhang H, Mori LP, Mirny LA, et al.
2025Research article
Design not recorded in structured metadata
27cc by
PMID 41107486 · DOI · PMC12700819
MDM2 functions as a timer reporting the length of mitosis
Fulcher LJ, Sobajima T, Batley C, Gibbs-Seymour I, Barr FA
2025Research article
Design not recorded in structured metadata
26cc by
PMID 39789219 · DOI · PMC11821534
Interphase chromosome conformation is specified by distinct folding programmes inherited through mitotic chromosomes or the cytoplasm
Schooley A, Venev SV, Aksenova V, Lehman JW, Navarrete E, Pai AA, et al.
2026Research article
Design not recorded in structured metadata
23cc by
PMID 41429936 · DOI · PMC12807859

Rules of engagement for condensins and cohesins guide mitotic chromosome formation [1]

Research article Samejima K, Gibcus JH, Abraham S, Cisneros-Soberanis F, Samejima I, Beckett AJ, et al. · · 2025 · cited 73 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
We used Hi-C, imaging, proteomics, and polymer modeling to define rules of engagement for SMC (structural maintenance of chromosomes) complexes as cells refold interphase chromatin into rod-shaped mitotic chromosomes.
Closing excerpt
The dynamics of Hi-C interactions and chromosome morphology reveal that during prophase, loops are extruded in vivo at ∼1 to 3 kilobases per second by condensins as they form a disordered discontinuous helical scaffold within individual chromatids.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (133 words)

We used Hi-C, imaging, proteomics, and polymer modeling to define rules of engagement for SMC (structural maintenance of chromosomes) complexes as cells refold interphase chromatin into rod-shaped mitotic chromosomes. First, condensin disassembles interphase chromatin loop organization by evicting or displacing extrusive cohesin. Second, condensin bypasses cohesive cohesins, thereby maintaining sister chromatid cohesion as sisters separate. Studies of mitotic chromosomes formed by cohesin, condensin II, and condensin I alone or in combination lead to refined models of mitotic chromosome conformation. In these models, loops are consecutive and not overlapping, implying that condensins stall upon encountering each other. The dynamics of Hi-C interactions and chromosome morphology reveal that during prophase, loops are extruded in vivo at ∼1 to 3 kilobases per second by condensins as they form a disordered discontinuous helical scaffold within individual chromatids.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40208986 · DOI · PMC12118822

Dynamics of microcompartment formation at the mitosis-to-G1 transition [2]

Research article Goel VY, Aboreden NG, Jusuf JM, Zhang H, Mori LP, Mirny LA, et al. · · 2025 · cited 27 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
As cells exit mitosis and enter G1, chromosomes decompact and transcription is reestablished.
Closing excerpt
Our results suggest that compaction and homotypic affinity drive microcompartment formation, which may explain transient transcriptional spiking at mitotic exit.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (153 words)

As cells exit mitosis and enter G1, chromosomes decompact and transcription is reestablished. Hi-C studies have indicated that all interphase three-dimensional genome features, including A/B compartments, topologically associating domains and CCCTC-binding factor loops, are lost during mitosis. However, Hi-C is insensitive to features such as microcompartments, nested focal interactions between cis-regulatory elements. Here we apply region capture Micro-C to mouse erythroblasts from mitosis to G1. We unexpectedly observe microcompartments in prometaphase, which strengthen in anaphase and telophase before weakening throughout G1. Microcompartment anchors coincide with transcriptionally spiking promoters during mitosis. Loss of condensin loop extrusion differentially impacts microcompartments and A/B compartments, suggesting that they are partially distinct. Polymer modeling shows that microcompartment formation is favored by chromatin compaction and disfavored by loop extrusion, providing a basis for strong microcompartmentalization in anaphase and telophase. Our results suggest that compaction and homotypic affinity drive microcompartment formation, which may explain transient transcriptional spiking at mitotic exit.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41107486 · DOI · PMC12700819

MDM2 functions as a timer reporting the length of mitosis [3]

Research article Fulcher LJ, Sobajima T, Batley C, Gibbs-Seymour I, Barr FA · · 2025 · cited 26 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Delays in mitosis trigger p53-dependent arrest in G1 of the next cell cycle, thus preventing repeated cycles of chromosome instability and aneuploidy.
Closing excerpt
Subsequent p53-dependent p21 accumulation then channels G1 cells into a sustained cell-cycle arrest, whereas abrogation of the response in p53-deficient cells allows them to bypass this crucial defence mechanism.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (150 words)

Delays in mitosis trigger p53-dependent arrest in G1 of the next cell cycle, thus preventing repeated cycles of chromosome instability and aneuploidy. Here we show that MDM2, the p53 ubiquitin ligase, is a key component of the timer mechanism triggering G1 arrest in response to prolonged mitosis. This timer function arises due to the attenuation of protein synthesis in mitosis. Because MDM2 has a short half-life and ongoing protein synthesis is therefore necessary to maintain its steady-state concentration, the amount of MDM2 gradually falls during mitosis but normally remains above a critical threshold for p53 regulation at the onset of G1. When mitosis is extended by prolonged spindle assembly checkpoint activation, the amount of MDM2 drops below this threshold, stabilizing p53. Subsequent p53-dependent p21 accumulation then channels G1 cells into a sustained cell-cycle arrest, whereas abrogation of the response in p53-deficient cells allows them to bypass this crucial defence mechanism.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 39789219 · DOI · PMC11821534

Interphase chromosome conformation is specified by distinct folding programmes inherited through mitotic chromosomes or the cytoplasm [4]

Research article Schooley A, Venev SV, Aksenova V, Lehman JW, Navarrete E, Pai AA, et al. · · 2026 · cited 23 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Identity-specific chromosome conformation must be re-established at each cell division.
Closing excerpt
The combined and interdependent action of chromosome-intrinsic and cytoplasmic inherited folding programmes determines the interphase chromatin conformation as cells exit mitosis.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (149 words)

Identity-specific chromosome conformation must be re-established at each cell division. To uncover how interphase folding is inherited, we developed an approach that segregates chromosome-intrinsic mechanisms from those propagated through the cytoplasm during G1 nuclear reassembly. Inducible degradation of proteins essential for the establishment of nucleocytoplasmic transport during mitotic exit enabled analysis of folding programmes with distinct modes of inheritance. Here we show that genome compartmentalization is driven entirely by chromosome-intrinsic factors. In addition to conventional compartmental segregation, the chromosome-intrinsic folding programme leads to prominent genome-scale microcompartmentalization of mitotically bookmarked cis-regulatory elements. The microcompartment conformation forms transiently during telophase and is subsequently modulated by a second folding programme inherited through the cytoplasm in early G1. This programme includes cohesin-mediated loop extrusion and factors involved in transcription and RNA processing. The combined and interdependent action of chromosome-intrinsic and cytoplasmic inherited folding programmes determines the interphase chromatin conformation as cells exit mitosis.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41429936 · DOI · PMC12807859

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Acetyl coenzyme A: a central metabolite and second messenger [5]
    Pietrocola F, Galluzzi L, Bravo-San Pedro JM, Madeo F, Kroemer G · Cell Metab · 2015 · cited 1,132 times (Europe PMC)
  • Research article Ki-67: more than a proliferation marker [6]
    Sun X, Kaufman PD · Chromosoma · 2018 · cited 738 times (Europe PMC)
  • Research article Microtubules and Microtubule-Associated Proteins [7]
    Goodson HV, Jonasson EM · Cold Spring Harb Perspect Biol · 2018 · cited 495 times (Europe PMC)
  • Research article Heterochromatin: Guardian of the Genome [8]
    Janssen A, Colmenares SU, Karpen GH · Annu Rev Cell Dev Biol · 2018 · cited 452 times (Europe PMC)
  • Research article Targeting Mitosis in Cancer: Emerging Strategies [9]
    Dominguez-Brauer C, Thu KL, Mason JM, Blaser H, Bray MR, Mak TW · Mol Cell · 2015 · cited 382 times (Europe PMC)
  • Research article Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton [10]
    Steinmetz MO, Prota AE · Trends Cell Biol · 2018 · cited 380 times (Europe PMC)

References

  1. Samejima K, Gibcus JH, Abraham S, Cisneros-Soberanis F, Samejima I, Beckett AJ, et al.. Rules of engagement for condensins and cohesins guide mitotic chromosome formation. . 2025. PMID 40208986 · DOI · PMC12118822
  2. Goel VY, Aboreden NG, Jusuf JM, Zhang H, Mori LP, Mirny LA, et al.. Dynamics of microcompartment formation at the mitosis-to-G1 transition. . 2025. PMID 41107486 · DOI · PMC12700819
  3. Fulcher LJ, Sobajima T, Batley C, Gibbs-Seymour I, Barr FA. MDM2 functions as a timer reporting the length of mitosis. . 2025. PMID 39789219 · DOI · PMC11821534
  4. Schooley A, Venev SV, Aksenova V, Lehman JW, Navarrete E, Pai AA, et al.. Interphase chromosome conformation is specified by distinct folding programmes inherited through mitotic chromosomes or the cytoplasm. . 2026. PMID 41429936 · DOI · PMC12807859
  5. Pietrocola F, Galluzzi L, Bravo-San Pedro JM, Madeo F, Kroemer G. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab. 2015. PMID 26039447 · DOI
  6. Sun X, Kaufman PD. Ki-67: more than a proliferation marker. Chromosoma. 2018. PMID 29322240 · DOI · PMC5945335
  7. Goodson HV, Jonasson EM. Microtubules and Microtubule-Associated Proteins. Cold Spring Harb Perspect Biol. 2018. PMID 29858272 · DOI · PMC5983186
  8. Janssen A, Colmenares SU, Karpen GH. Heterochromatin: Guardian of the Genome. Annu Rev Cell Dev Biol. 2018. PMID 30044650 · DOI
  9. Dominguez-Brauer C, Thu KL, Mason JM, Blaser H, Bray MR, Mak TW. Targeting Mitosis in Cancer: Emerging Strategies. Mol Cell. 2015. PMID 26590712 · DOI
  10. Steinmetz MO, Prota AE. Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton. Trends Cell Biol. 2018. PMID 29871823 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • MeiosisMolecular Biology
  • ProphaseMolecular Biology
  • MetaphaseMolecular Biology
  • AnaphaseMolecular Biology
  • Cell DivisionMolecular Biology
  • G2 PhaseMolecular Biology

All 100 articles in Molecular Biology →

At a glance

61,551
PubMed records on this heading
7%
published since 2020
5,024
review articles
52
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • MeiosisMolecular Biology
  • ProphaseMolecular Biology
  • MetaphaseMolecular Biology
  • AnaphaseMolecular Biology
  • Cell DivisionMolecular Biology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support